Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer
Clinical trial NCT05552001 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05552001
- Sponsor
- UNICANCER
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-05
- Primary completion
- 2026-10-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.